Viewing Study NCT00265759


Ignite Creation Date: 2025-12-24 @ 2:34 PM
Ignite Modification Date: 2026-02-01 @ 1:15 PM
Study NCT ID: NCT00265759
Status: COMPLETED
Last Update Posted: 2025-04-23
First Post: 2005-12-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View
None estrogen receptor-positive breast cancer View